The applications of generative artificial intelligence (GenAI) have reached continuous glucose monitoring after DexCom launched rolled out the technology into its glucose biosensor products. Built ...
SINGAPORE - The Health Sciences Authority (HSA) said SD Biosensor and Flowflex antigen rapid test (ART) kits involved in a recall in the United States are safe and fit for use in Singapore. The ...
The Health Sciences Authority (HSA) has said SD Biosensor and Flowflex antigen rapid test (ART) kits linked to a recall in the United States are safe and fit for use in Singapore. Its statement ...